Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Curr Opin Immunol. 2020 Dec;67:95-105. doi: 10.1016/j.coi.2020.10.013. Epub 2020 Nov 23.
The innate immune system, the first line of defense against pathogens and host tissue damage, initiates pro-inflammatory responses which, when dysregulated, promote inflammation to drive a broad range of autoimmune diseases. Immunomodulatory therapies have been developed to successfully treat several autoimmune diseases, but still many others lack effective treatments. Here, we explore recent advances in how the innate immune system contributes to autoinflammation, from the innate immune sensors that initiate immune responses to how this system regulates the activation of programmed cell death pathways including pyroptosis, apoptosis, necroptosis, and PANoptosis, which involves machinery from the pyroptotic, apoptotic, and necroptotic pathways. Recent advances in our understanding of innate immunity raise important considerations for developing new inflammatory disease treatments that target innate immune signaling and programmed cell death pathways.
固有免疫系统是抵御病原体和宿主组织损伤的第一道防线,它会引发促炎反应,而当这种反应失调时,就会促进炎症反应,从而引发广泛的自身免疫性疾病。已经开发出免疫调节疗法来成功治疗几种自身免疫性疾病,但仍有许多疾病缺乏有效治疗方法。在这里,我们探讨了固有免疫系统如何导致自身炎症的最新进展,包括引发免疫反应的固有免疫传感器,以及该系统如何调节包括细胞焦亡、细胞凋亡、细胞坏死和多细胞凋亡在内的程序性细胞死亡途径的激活,其中涉及细胞焦亡、细胞凋亡和细胞坏死途径的机制。我们对固有免疫的理解的最新进展提出了重要的考虑因素,即开发新的针对固有免疫信号和程序性细胞死亡途径的炎症性疾病治疗方法。